Biofrontera Inc. (BFRI) vs Kiora Pharmaceuticals, Inc. (KPRX)

A side-by-side comparison of Biofrontera Inc. and Kiora Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Biofrontera Inc. logo
BFRI
Biofrontera Inc.
$12M
$0.92HealthcareDelayed quote: Oct 6, 2026, 2:58 PM EDT
Kiora Pharmaceuticals, Inc. logo
KPRX
Kiora Pharmaceuticals, Inc.
$11M
$2.51HealthcareDelayed quote: Oct 6, 2026, 2:58 PM EDT

Total return — BFRI vs KPRX

growth of $100 · dividends reinvested · last 5y
BFRI -99.0% (-60.1%/yr)KPRX -99.6% (-67.3%/yr)BFRI compounded faster over this window
0100200300Start $10020222023202420252026$1$0
BFRI KPRX

BFRI vs KPRX: by the numbers

  • •BFRI is the larger company ($12M vs $11M market cap).
  • •Both run net losses; KPRX's is the smaller (0.00% vs -13.78% net margin).

Metrics side by side

Valuation

MetricBFRIKPRX
P/S ratio0.25N/A
P/B ratio1.980.66

Profitability

MetricBFRIKPRX
Gross margin84.45%0.00%
Operating margin-21.94%0.00%
Net margin-13.78%0.00%
ROE-106.87%-65.18%
ROIC-32.27%-59.42%

Growth (annualized)

MetricBFRIKPRX
Revenue CAGR (5Y)15.55%N/A
Total return CAGR (5Y)N/A-67.06%

Go deeper

Full BFRI analysisFull KPRX analysisInteractive comparison tool

Dig into the metrics

Biofrontera ROEKiora Pharmaceuticals ROEBiofrontera operating marginKiora Pharmaceuticals operating marginBiofrontera revenue growthKiora Pharmaceuticals revenue growthBiofrontera free cash flowKiora Pharmaceuticals free cash flow

Biofrontera & Kiora Pharmaceuticals appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.